These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 26634615)

  • 1. Who benefits more from hemodynamically guided hypotensive therapy? The experience from two randomized, prospective and controlled trials.
    Krzesiński P; Gielerak G; Stańczyk A; Piotrowicz K; Skrobowski A
    Ther Adv Cardiovasc Dis; 2016 Feb; 10(1):21-9. PubMed ID: 26634615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of hemodynamically-guided hypotensive therapy in one-year observation: Randomized, prospective and controlled trial (FINEPATH study).
    Krzesiński P; Gielerak G; Stańczyk A; Piotrowicz K; Uziębło-Życzkowska B; Banak M; Kurpaska M; Michalczyk Ł; Jurek A; Wolszczak K; Galas A; Wójcik A; Skrobowski A
    Cardiol J; 2016; 23(2):132-40. PubMed ID: 26876066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of impedance cardiography in optimisation of antihypertensive treatment in patients with metabolic syndrome: a randomised prospective clinical trial.
    Krzesiński P; Gielerak G; Kowal J; Piotrowicz K
    Kardiol Pol; 2012; 70(6):599-607. PubMed ID: 22718380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of an impedance cardiography guided treatment strategy to improve blood pressure control in a real-world setting: results from a pragmatic clinical trial.
    Lu Y; Wang L; Wang H; Gu J; Ma ZJ; Lian Z; Zhang Z; Krumholz H; Sun N
    Open Heart; 2021 Sep; 8(2):. PubMed ID: 34580169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualizing hypertension treatment with impedance cardiography: a meta-analysis of published trials.
    Ferrario CM; Flack JM; Strobeck JE; Smits G; Peters C
    Ther Adv Cardiovasc Dis; 2010 Feb; 4(1):5-16. PubMed ID: 20042450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
    Lacourcière Y; Neutel JM; Davidai G; Koval S
    Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A "patient-tailored" treatment of hypertension with use of impedance cardiography: a randomized, prospective and controlled trial.
    Krzesiński P; Gielerak GG; Kowal JJ
    Med Sci Monit; 2013 Apr; 19():242-50. PubMed ID: 23558598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
    Punzi HA
    Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):12-21. PubMed ID: 24492985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocol.
    Radauceanu A; Boivin JM; Bernaud C; Fay R; Zannad F;
    Fundam Clin Pharmacol; 2004 Aug; 18(4):483-91. PubMed ID: 15312156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients.
    Hermida RC; Ayala DE; Crespo JJ; Mojón A; Chayán L; Fontao MJ; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):176-91. PubMed ID: 23077974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM.
    Oigman W; Gomes MA; Pereira-Barretto AC; Póvoa R; Kohlmann O; Rocha JC; Nobre F
    Clin Ther; 2013 May; 35(5):702-10. PubMed ID: 23623755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in blood pressure control with impedance cardiography-guided pharmacologic decision making.
    Sharman DL; Gomes CP; Rutherford JP
    Congest Heart Fail; 2004; 10(1):54-8. PubMed ID: 14872160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure control by the nifedipine GITS-telmisartan combination in patients at high cardiovascular risk: the TALENT study.
    Mancia G; Parati G; Bilo G; Choi J; Kilama MO; Ruilope LM;
    J Hypertens; 2011 Mar; 29(3):600-9. PubMed ID: 21252701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels--overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2014 Dec; 32(12):2296-304. PubMed ID: 25259547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of home and office blood pressure in hypertensive patients treated with enalapril/HCTZ 20/6 mg: the ESPADA study.
    Campo C; Fernández G; González-Esteban J; Segura J; Ruilope LM;
    Blood Press; 2000; 9(6):355-62. PubMed ID: 11212065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension.
    Mallion JM; Omboni S; Barton J; Van Mieghem W; Narkiewicz K; Panzer PK; Puig JG; Stefanadis C; Zweiker R;
    Blood Press Suppl; 2011 Apr; 1():3-11. PubMed ID: 21091270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.